{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:15:58Z","timestamp":1776071758386,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Science and Technology Council","award":["NSTC 113-2221-E-006-168"],"award-info":[{"award-number":["NSTC 113-2221-E-006-168"]}]},{"name":"Yushan Fellow Program, Ministry of Education (MOE), Taiwan","award":["MOE-109-YSFEE-0005-003-P1"],"award-info":[{"award-number":["MOE-109-YSFEE-0005-003-P1"]}]},{"name":"Higher Education Sprout Project, MOE, to the Headquarters of University Advancement at National Cheng Kung University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s11060-026-05464-z","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T10:26:34Z","timestamp":1771496794000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early withdrawal of systemic corticosteroid following malignant glioma craniotomy: a real-world population-based cohort study"],"prefix":"10.1007","volume":"177","author":[{"given":"Chia-En","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Chen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsuan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pang-Shuo","family":"Perng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yen-Ta","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng-Juei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ching-Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Shun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"5464_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/NEUONC\/NOAF177","author":"PY Wen","year":"2025","unstructured":"Wen PY, Weller M, Lee EQ et al (2025) Glioblastoma in adults: A society for Neuro-Oncology (SNO) and European society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro Oncol. https:\/\/doi.org\/10.1093\/NEUONC\/NOAF177","journal-title":"Neuro Oncol"},{"key":"5464_CR2","doi-asserted-by":"publisher","unstructured":"Singh S, Dey D, Barik D et al (2025) Glioblastoma at the crossroads: current understanding and future therapeutic horizons. Signal Transduct Target Ther 10:1 10:213. https:\/\/doi.org\/10.1038\/s41392-025-02299-4","DOI":"10.1038\/s41392-025-02299-4"},{"key":"5464_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/NOP\/NPU029","volume":"2","author":"P Roth","year":"2014","unstructured":"Roth P, Happold C, Weller M (2014) Corticosteroid use in neuro-oncology: an update. Neurooncol Pract 2:6. https:\/\/doi.org\/10.1093\/NOP\/NPU029","journal-title":"Neurooncol Pract"},{"key":"5464_CR4","doi-asserted-by":"publisher","first-page":"1335730","DOI":"10.3389\/FONC.2023.1335730\/BIBTEX","volume":"13","author":"AM Mistry","year":"2023","unstructured":"Mistry AM (2023) Perioperative dexamethasone in high-grade gliomas: the short-term benefits and long-term harms. Front Oncol 13:1335730. https:\/\/doi.org\/10.3389\/FONC.2023.1335730\/BIBTEX","journal-title":"Front Oncol"},{"key":"5464_CR5","doi-asserted-by":"publisher","first-page":"1632231","DOI":"10.3389\/FNEUR.2025.1632231","volume":"16","author":"V Prasad","year":"2025","unstructured":"Prasad V, Elhag A, Onyiriuka L et al (2025) Dexamethasone in brain tumor patients: a real-world pharmacovigilance audit. Front Neurol 16:1632231. https:\/\/doi.org\/10.3389\/FNEUR.2025.1632231","journal-title":"Front Neurol"},{"key":"5464_CR6","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.7150\/THNO.40908","volume":"10","author":"D McMahon","year":"2020","unstructured":"McMahon D, Oakden W, Hynynen K (2020) Investigating the effects of dexamethasone on blood-brain barrier permeability and inflammatory response following focused ultrasound and microbubble exposure. Theranostics 10:1604. https:\/\/doi.org\/10.7150\/THNO.40908","journal-title":"Theranostics"},{"key":"5464_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/S11060-019-03238-4","volume":"144","author":"CAC Jessurun","year":"2019","unstructured":"Jessurun CAC, Hulsbergen AFC, Cho LD et al (2019) Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know? J Neurooncol 144:249. https:\/\/doi.org\/10.1007\/S11060-019-03238-4","journal-title":"J Neurooncol"},{"key":"5464_CR8","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.3747\/CO.21.1769","volume":"21","author":"X Kostaras","year":"2014","unstructured":"Kostaras X, Cusano F, Kline GA et al (2014) Use of dexamethasone in patients with high-grade glioma: a clinical practice guideline. Curr Oncol 21:e493. https:\/\/doi.org\/10.3747\/CO.21.1769","journal-title":"Curr Oncol"},{"key":"5464_CR9","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/BRAIN\/AWW046","volume":"139","author":"KL Pitter","year":"2016","unstructured":"Pitter KL, Tamagno I, Alikhanyan K et al (2016) Corticosteroids compromise survival in glioblastoma. Brain 139:1458\u20131471. https:\/\/doi.org\/10.1093\/BRAIN\/AWW046","journal-title":"Brain"},{"key":"5464_CR10","doi-asserted-by":"publisher","first-page":"vdac087","DOI":"10.1093\/NOAJNL\/VDAC087","volume":"4","author":"KX Swildens","year":"2022","unstructured":"Swildens KX, Sillevis Smitt PAE, Van Den Bent MJ et al (2022) The effect of dexamethasone on the microenvironment and efficacy of checkpoint inhibitors in glioblastoma: a systematic review. Neurooncol Adv 4:vdac087. https:\/\/doi.org\/10.1093\/NOAJNL\/VDAC087","journal-title":"Neurooncol Adv"},{"key":"5464_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/S40425-018-0371-5","volume":"6","author":"AJ Giles","year":"2018","unstructured":"Giles AJ, Hutchinson MKND, Sonnemann HM et al (2018) Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. J Immunother Cancer 6:51. https:\/\/doi.org\/10.1186\/S40425-018-0371-5","journal-title":"J Immunother Cancer"},{"key":"5464_CR12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1177\/0271678X19859847","volume":"39","author":"D Dubinski","year":"2019","unstructured":"Dubinski D, Hattingen E, Senft C et al (2019) Controversial roles for dexamethasone in glioblastoma \u2013 Opportunities for novel vascular targeting therapies. J Cereb Blood Flow Metab 39:1460\u20131468. https:\/\/doi.org\/10.1177\/0271678X19859847;PAGE:STRING:ARTICLE\/CHAPTER","journal-title":"J Cereb Blood Flow Metab"},{"key":"5464_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.neulet.2006.11.072","volume":"413","author":"Yting Gu","year":"2007","unstructured":"Gu Yting, Zhang H, Xue Yxue (2007) Dexamethasone treatment modulates aquaporin-4 expression after intracerebral hemorrhage in rats. Neurosci Lett 413:126\u2013131. https:\/\/doi.org\/10.1016\/j.neulet.2006.11.072","journal-title":"Neurosci Lett"},{"key":"5464_CR14","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3390\/CANCERS16071393","volume":"16","author":"P Scheffler","year":"2024","unstructured":"Scheffler P, Fung C, Momjian S et al (2024) Dexamethasone in patients with glioblastoma: A systematic review and Meta-Analysis. Cancers (Basel) 16:1393. https:\/\/doi.org\/10.3390\/CANCERS16071393","journal-title":"Cancers (Basel)"},{"key":"5464_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/BJC.2015.238","volume":"113","author":"ET Wong","year":"2015","unstructured":"Wong ET, Lok E, Gautam S, Swanson KD (2015) Dexamethasone exerts profound Immunologic interference on treatment efficacy for recurrent glioblastoma. Br J Cancer 113:232. https:\/\/doi.org\/10.1038\/BJC.2015.238","journal-title":"Br J Cancer"},{"key":"5464_CR16","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.4049\/JIMMUNOL.164.4.1768","volume":"164","author":"D Franchimont","year":"2000","unstructured":"Franchimont D, Galon J, Gadina M et al (2000) Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. J Immunol 164:1768\u20131774. https:\/\/doi.org\/10.4049\/JIMMUNOL.164.4.1768","journal-title":"J Immunol"},{"key":"5464_CR17","doi-asserted-by":"publisher","first-page":"e1358839","DOI":"10.1080\/2162402X.2017.1358839","volume":"6","author":"G Chitadze","year":"2017","unstructured":"Chitadze G, Fl\u00fch C, Quabius ES et al (2017) In-depth immunophenotyping of patients with glioblastoma multiforme: impact of steroid treatment. Oncoimmunology 6:e1358839. https:\/\/doi.org\/10.1080\/2162402X.2017.1358839","journal-title":"Oncoimmunology"},{"key":"5464_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-022-33215-x","volume":"13","author":"JK Wiencke","year":"2022","unstructured":"Wiencke JK, Molinaro AM, Warrier G et al (2022) DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival. Nat Commun 2022 13:1. https:\/\/doi.org\/10.1038\/s41467-022-33215-x","journal-title":"Nat Commun 2022"},{"key":"5464_CR19","doi-asserted-by":"crossref","unstructured":"Carenza C, Franzese S, Castagna A et al (2023) Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas. Front Immunol 13:1074762. https:\/\/doi.org\/10.3389\/FIMMU.2022.1074762\/BIBTEX","DOI":"10.3389\/fimmu.2022.1074762"},{"key":"5464_CR20","doi-asserted-by":"publisher","first-page":"582106","DOI":"10.3389\/FIMMU.2020.582106","volume":"11","author":"JRD Pearson","year":"2020","unstructured":"Pearson JRD, Cuzzubbo S, McArthur S et al (2020) Immune escape in glioblastoma multiforme and the adaptation of immunotherapies for treatment. Front Immunol 11:582106. https:\/\/doi.org\/10.3389\/FIMMU.2020.582106","journal-title":"Front Immunol"},{"key":"5464_CR21","doi-asserted-by":"publisher","first-page":"1590781","DOI":"10.3389\/FIMMU.2025.1590781\/FULL","volume":"16","author":"D Jiang","year":"2025","unstructured":"Jiang D, Li Y (2025) Unraveling the immunosuppressive microenvironment of glioblastoma and advancements in treatment. Front Immunol 16:1590781. https:\/\/doi.org\/10.3389\/FIMMU.2025.1590781\/FULL","journal-title":"Front Immunol"},{"key":"5464_CR22","doi-asserted-by":"publisher","first-page":"e0312764","DOI":"10.1371\/JOURNAL.PONE.0312764","volume":"20","author":"H Cheng","year":"2025","unstructured":"Cheng H, Yan Y, Zhang B et al (2025) Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in glioblastoma. PLoS ONE 20:e0312764. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0312764","journal-title":"PLoS ONE"},{"key":"5464_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1158\/1078-0432.CCR-20-2291\/353525\/","volume":"27","author":"J Bryan Iorgulescu","year":"2021","unstructured":"Bryan Iorgulescu J, Gokhale PC, Speranza MC et al (2021) Concurrent dexamethasone limits the clinical benefit of immune checkpoint Blockade in glioblastoma. Clin Cancer Res 27:276\u2013287. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-2291\/353525\/P\/CONCURRENT-DEXAMETHASONE-LIMITS-THE-CLINICAL","journal-title":"Clin Cancer Res"},{"key":"5464_CR24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1007\/S00415-020-09731-5","volume":"268","author":"F Petrelli","year":"2021","unstructured":"Petrelli F, De Stefani A, Ghidini A et al (2021) Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis. J Neurol 268:440\u2013447. https:\/\/doi.org\/10.1007\/S00415-020-09731-5","journal-title":"J Neurol"},{"key":"5464_CR25","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/CAAC.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan AC, Ashley DM, L\u00f3pez GY et al (2020) Management of glioblastoma: state of the art and future directions. CA Cancer J Clin 70(4):299\u2013312. https:\/\/doi.org\/10.3322\/CAAC.21613;REQUESTEDJOURNAL:JOURNAL:15424863;WGROUP:STRING:PUBLICATION","journal-title":"CA Cancer J Clin"},{"key":"5464_CR26","doi-asserted-by":"publisher","unstructured":"Bessette J, Arditi J, Noreck J et al (2025) Medical comorbidities prognosticate survival in glioblastoma. BJC Reports 2025 3:1 3:75. https:\/\/doi.org\/10.1038\/s44276-025-00189-4","DOI":"10.1038\/s44276-025-00189-4"},{"key":"5464_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/1941874413510920","volume":"4","author":"AE Merkler","year":"2014","unstructured":"Merkler AE, Saini V, Kamel H, Stieg PE (2014) Preoperative steroid use and the risk of infectious complications after neurosurgery. Neurohospitalist 4:80. https:\/\/doi.org\/10.1177\/1941874413510920","journal-title":"Neurohospitalist"},{"key":"5464_CR28","doi-asserted-by":"publisher","first-page":"e254689","DOI":"10.1001\/JAMANETWORKOPEN.2025.4689","volume":"8","author":"D Wasilewski","year":"2025","unstructured":"Wasilewski D, Araceli T, Rafaelian A et al (2025) Practice variation in perioperative dexamethasone use and outcomes in brain metastasis resection. JAMA Netw Open 8:e254689\u2013e254689. https:\/\/doi.org\/10.1001\/JAMANETWORKOPEN.2025.4689","journal-title":"JAMA Netw Open"},{"key":"5464_CR29","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/J.JID.2017.01.024","volume":"137","author":"AT Slominski","year":"2017","unstructured":"Slominski AT, Zmijewski MA (2017) Glucocorticoids inhibit wound healing: novel mechanism of action. J Invest Dermatol 137:1012. https:\/\/doi.org\/10.1016\/J.JID.2017.01.024","journal-title":"J Invest Dermatol"},{"key":"5464_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1001\/JAMAINTERNMED.2013.122","volume":"173","author":"SA Johannesdottir","year":"2013","unstructured":"Johannesdottir SA, Horv\u00e1th-Puh\u0301o E, Dekkers OM et al (2013) Use of glucocorticoids and risk of venous thromboembolism: A nationwide Population-Based Case-Control study. JAMA Intern Med 173:743\u2013752. https:\/\/doi.org\/10.1001\/JAMAINTERNMED.2013.122","journal-title":"JAMA Intern Med"},{"key":"5464_CR31","doi-asserted-by":"publisher","first-page":"226559","DOI":"10.3389\/FIMMU.2016.00592\/FULL","volume":"7","author":"KA Zieli\u0144ska","year":"2016","unstructured":"Zieli\u0144ska KA, Moortel L, Van, Opdenakker G et al (2016) Endothelial response to glucocorticoids in inflammatory diseases. Front Immunol 7:226559. https:\/\/doi.org\/10.3389\/FIMMU.2016.00592\/FULL","journal-title":"Front Immunol"},{"key":"5464_CR32","doi-asserted-by":"publisher","first-page":"918356","DOI":"10.3389\/FENDO.2022.918356","volume":"13","author":"MJ Einarsdottir","year":"2022","unstructured":"Einarsdottir MJ, Ekman P, Molin M et al (2022) High mortality rate in oral glucocorticoid users: A Population-Based matched cohort study. Front Endocrinol (Lausanne) 13:918356. https:\/\/doi.org\/10.3389\/FENDO.2022.918356","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5464_CR33","doi-asserted-by":"publisher","first-page":"898873","DOI":"10.3389\/FONC.2022.898873","volume":"12","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Ji P, Wang S et al (2022) Early unplanned reoperation after glioma craniotomy: Incidence, predictor and process improvement. Front Oncol 12:898873. https:\/\/doi.org\/10.3389\/FONC.2022.898873","journal-title":"Front Oncol"},{"key":"5464_CR34","doi-asserted-by":"publisher","first-page":"e845","DOI":"10.1016\/j.wneu.2017.10.110","volume":"109","author":"R D\u00edez Valle","year":"2018","unstructured":"D\u00edez Valle R, Becerra Castro V, Marigil S\u00e1nchez M et al (2018) Results of a policy of fast tapering of steroids after resection surgery in glioblastoma. World Neurosurg 109:e845\u2013e852. https:\/\/doi.org\/10.1016\/j.wneu.2017.10.110","journal-title":"World Neurosurg"},{"key":"5464_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3171\/2015.4.JNS142200","volume":"124","author":"R Babu","year":"2016","unstructured":"Babu R, Komisarow JM, Agarwal VJ et al (2016) Glioblastoma in the elderly: the effect of aggressive and modern therapies on survival. J Neurosurg 124:998\u20131007. https:\/\/doi.org\/10.3171\/2015.4.JNS142200","journal-title":"J Neurosurg"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05464-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05464-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T08:37:40Z","timestamp":1776069460000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05464-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,19]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["5464"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05464-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,19]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of National Cheng Kung University Hospital (approval number: A-ER-113-439). Informed consent was waived, as approved by the Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Generative AI was not used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI statement"}},{"value":"None","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Presentation"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}